Advances in the Surgical Treatment of Neuroblastoma: A Review

Abstract

Neuroblastoma prognosis varies tremendously based on the stage and biologic features of the tumor. Treatment varies depending on the risk group and can range from surgery alone for stage 1 tumors to aggressive multimodality treatment for MYCN-amplified tumors. Although surgery plays a role in the diagnosis and management of all stages of neuroblastoma, the importance of that role, especially the extent of resection, in high-risk neuroblastoma continues to evolve. In the past five years, there have been several advances in neuroblastoma surgery. Studies have demonstrated that patients with low-risk disease can be treated with surgery alone, and in a subset of patients who are neonatally diagnosed with adrenal tumors, surgery can be avoided in 80%. Recent abstracts have supported a role for >90% resection of the primary tumor in high-risk patients. This article also reviews the surgical approaches to difficult thoracic and abdominal tumors, as well as the role for minimally invasive surgery in the management of localized neuroblastoma.

Keywords

neuroblastoma - abdominal tumors - MYCN

• References

• 1 Brodeur GM, Pritchard J, Berthold F , et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 1993; 11 (8) 1466-1477
• 2 Cohn SL, Pearson AD, London WB , et al; INRG Task Force. The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report. J Clin Oncol 2009; 27 (2) 289-297
• 3 Monclair T, Brodeur GM, Ambros PF , et al; INRG Task Force. The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report. J Clin Oncol 2009; 27 (2) 298-303
• 4 Kohler JA, Rubie H, Castel V , et al. Treatment of children over the age of one year with unresectable localised neuroblastoma without MYCN amplification: results of the SIOPEN study. Eur J Cancer 2013; 49 (17) 3671-3679
• 5 Strother DR, London WB, Schmidt ML , et al. Outcome after surgery alone or with restricted use of chemotherapy for patients with low-risk neuroblastoma: results of Children's Oncology Group study P9641. J Clin Oncol 2012; 30 (15) 1842-1848
• 6 Baker DL, Schmidt ML, Cohn SL , et al; Children's Oncology Group. Outcome after reduced chemotherapy for intermediate-risk neuroblastoma. N Engl J Med 2010; 363 (14) 1313-1323
• 7 Modak S, Kushner BH, LaQuaglia MP, Kramer K, Cheung NK. Management and outcome of stage 3 neuroblastoma. Eur J Cancer 2009; 45 (1) 90-98
• 8 Günther P, Holland-Cunz S, Schupp CJ, Stockklausner C, Hinz U, Schenk JP. Significance of image-defined risk factors for surgical complications in patients with abdominal neuroblastoma. Eur J Pediatr Surg 2011; 21 (5) 314-317
• 9 Warmann SW, Seitz G, Schaefer JF, Scheel-Walter HG, Leuschner I, Fuchs J. Vascular encasement as element of risk stratification in abdominal neuroblastoma. Surg Oncol 2011; 20 (4) 231-235
• 10 Rich BS, McEvoy MP, Kelly NE , et al. Resectability and operative morbidity after chemotherapy in neuroblastoma patients with encasement of major visceral arteries. J Pediatr Surg 2011; 46 (1) 103-107
• 11 Rubie H, De Bernardi B, Gerrard M , et al. Excellent outcome with reduced treatment in infants with nonmetastatic and unresectable neuroblastoma without MYCN amplification: results of the prospective INES 99.1. J Clin Oncol 2011; 29 (4) 449-455
• 12 Du L, Liu L, Zhang C , et al. Role of surgery in the treatment of patients with high-risk neuroblastoma who have a poor response to induction chemotherapy. J Pediatr Surg 2014; 49 (4) 528-533
• 13 Simon T, Häberle B, Hero B, von Schweinitz D, Berthold F. Role of surgery in the treatment of patients with stage 4 neuroblastoma age 18 months or older at diagnosis. J Clin Oncol 2013; 31 (6) 752-758
• 14 La Quaglia MP. State of the art in oncology: high risk neuroblastoma, alveolar rhabdomyosarcoma, desmoplastic small round cell tumor, and POST-TEXT 3 and 4 hepatoblastoma. J Pediatr Surg 2014; 49 (2) 233-240
• 15 Von Allmen D, Davidoff AM, London WB , et al. Influence of extent of resection on survival in high risk neuroblastoma patients: a report from the COAG A3973 study [abstract OR076]. In: Advances in Neuroblastoma Research: ANR 2014 Conference Proceedings (Cologne, Germany). Frechen, Germany: Welcome Veranstaltungs GmbH; 2014:131
• 16 Holmes K, Sarnacki S, Monclair T , et al. Influence of surgical excision on survival of patients with high risk neuroblastoma. Report from Study 1 of SIOP Europe (SIOPEN) [abstract PL012]. In: Advances in Neuroblastoma Research: ANR 2014 Conference Proceedings (Cologne, Germany). Frechen, Germany: Welcome Veranstaltungs GmbH; 2014:107
• 17 Rich BS, McEvoy MP, LaQuaglia MP, Wolden SL. Local control, survival, and operative morbidity and mortality after re-resection, and intraoperative radiation therapy for recurrent or persistent primary high-risk neuroblastoma. J Pediatr Surg 2011; 46 (1) 97-102
• 18 Christison-Lagay ER, Darcy DG, Stanelle EJ, Dasilva S, Avila E, La Quaglia MP. “Trap-door” and “clamshell” surgical approaches for the management of pediatric tumors of the cervicothoracic junction and mediastinum. J Pediatr Surg 2014; 49 (1) 172-176 , discussion 176–177
• 19 Kelleher CM, Smithson L, Nguyen LL , et al. Clinical outcomes in children with adrenal neuroblastoma undergoing open versus laparoscopic adrenalectomy. J Pediatr Surg 2013; 48 (8) 1727-1732
• 20 Mattioli G, Avanzini S, Prato AP , et al. Laparoscopic resection of adrenal neuroblastoma without image-defined risk factors: a prospective study on 21 consecutive pediatric patients. Pediatr Surg Int 2014; 30 (4) 387-394
• 21 Irtan S, Brisse HJ, Minard-Colin V, Schleiermacher G, Canale S, Sarnacki S. Minimally invasive surgery of neuroblastic tumors in children: Indications depend on anatomical location and image-defined risk factors [Epub ahead of print]. Pediatr Blood Cancer 2014; ;doi: 10.1002/pbc.25248
• 22 Malek MM, Mollen KP, Kane TD, Shah SR, Irwin C. Thoracic neuroblastoma: a retrospective review of our institutional experience with comparison of the thoracoscopic and open approaches to resection. J Pediatr Surg 2010; 45 (8) 1622-1626
• 23 Fraga JC, Rothenberg S, Kiely E, Pierro A. Video-assisted thoracic surgery resection for pediatric mediastinal neurogenic tumors. J Pediatr Surg 2012; 47 (7) 1349-1353